Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models

NCT06366932 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Second-line systemic treatment
OTHER: Folllow-up of second-line systemic treatment already started

Sponsor

Instituto de Investigación Hospital Universitario La Paz